Esperion Therapeutics, Inc.
ESPR
Revenue
73.83M
▼-63.90M▼-46.39%
3 Months ChangeAssets
352.32M
▼-20.74M▼-5.56%
3 Months ChangeLiabilities
696.54M
▲29.18M▲4.37%
3 Months ChangeFree Cash Flow
53.76M
▲108.11M▲198.89%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-12
Form 10-Q
ID: 0001628280-24-036762
2024-08-12
Form 8-K
ID: 0001628280-24-036597
2024-08-05
Form 8-K
ID: 0001628280-24-034766
2024-06-28
Form 8-K
ID: 0001628280-24-030403
2024-05-28
Form 8-K
ID: 0001628280-24-025418
2024-05-08
Form 8-K
ID: 0001628280-24-021717
2024-05-07
Form 10-Q
ID: 0001628280-24-020862
2024-05-07
Form 8-K
ID: 0001628280-24-020841
2024-02-27
Form 8-K
ID: 0001628280-24-007035
2024-01-22
Form 8-K
ID: 0001104659-24-005351